GE HealthCare Technologies Inc.
GEHC NASDAQHealthcare ★★★★★Latest Earnings
Date
Jul 29, 2026
ET
EPS Est.
1.04
EPS Actual
1.13
Revenue Est.
$5.26B
Revenue Actual
$5.3B
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
1.21
Revenue Est.
$5.35B
Company Overview
GE HealthCare Technologies Inc. (ticker GEHC) is listed on NASDAQ with a market cap of about $33.8B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), Pre-market, with consensus EPS of 1.21. In the last 14 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Jan 30, 2023 → Jul 29, 2026
Jan 30, 2023Range: 0.85 ~ 1.45Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 1.04 | 1.13 | $5.26B | $5.3B |
| Apr 29, 2026 | -- | 1.04 | 0.99 | $5.04B | $5.13B |
| Feb 4, 2026 | -- | 1.40 | 1.44 | $5.61B | $5.7B |
| Oct 29, 2025 | -- | 1.05 | 1.07 | $5.09B | $5.14B |
| Jul 30, 2025 | -- | 0.92 | Above forecast↑1.06 | $4.97B | $5.01B |
| Apr 30, 2025 | -- | 0.91 | 1.01 | $4.66B | $4.78B |
| Feb 13, 2025 | -- | 1.26 | Above forecast↑1.45 | $5.33B | $5.32B |
| Oct 30, 2024 | -- | 1.05 | 1.14 | $4.87B | $4.86B |
| Jul 31, 2024 | -- | 0.98 | 1.00 | $4.88B | $4.84B |
| Apr 30, 2024 | -- | 0.91 | 0.90 | $4.8B | $4.65B |
| Feb 6, 2024 | -- | 1.07 | 1.18 | $5.09B | $5.21B |
| Oct 31, 2023 | -- | 0.90 | 0.99 | $4.8B | $4.82B |
| Jul 25, 2023 | -- | 0.87 | 0.92 | $4.79B | $4.82B |
| Apr 25, 2023 | -- | 0.79 | 0.85 | $4.63B | $4.71B |
| Jan 30, 2023 | -- | -- | 1.31 | $4.9B | $4.94B |
Original Filings (SEC)
8-K2026-08-18 ↗
8-K2026-07-29 ↗
10-Q2026-07-29 ↗
8-K2026-07-29 ↗
8-K2026-07-23 ↗
8-K2026-05-11 ↗
10-Q2026-04-29 ↗
8-K2026-04-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
